<DOC>
	<DOCNO>NCT01238393</DOCNO>
	<brief_summary>The purpose study determine whether intraocular injection ranibizumab decrease retinal thickness patient epiretinal membrane reduces associate symptom .</brief_summary>
	<brief_title>Treatment Epiretinal Membranes With Ranibizumab</brief_title>
	<detailed_description />
	<mesh_term>Epiretinal Membrane</mesh_term>
	<mesh_term>Ranibizumab</mesh_term>
	<criteria>symptomatic idiopathic epiretinal membrane vision worse 6/18 fit surgery prior vitreoretinal surgery injection diabetes past current form retinal vein occlusion neovascularization agerelated macular degeneration condition cause significant limitation visual potential</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>